Last updated on June 2018

Optimal Research is enrolling healthy adults ages 18-45 for a vaccine research study for the Chikungunya virus. Compensation may be provided to qualified participants up to $1550.00 for this 13 visit study.


Brief description of study

Chikungunya Vaccine research study lasts 13 visits. Compensation may be provided to qualified participants up to $1550.00.

Clinical Study Identifier: TX202129

Contact Investigators or Research Sites near you

Start Over

LuAnne Boggs, Center Manager

Optimal Research Huntsville
Huntsville, AL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.